ACE and Hodgkins lymphoma: An important limitation of the above-mentioned studies is that the actual efficacy of statins, angiotensin-converting enzyme inhibitors, and β-blockers in survivors of HL and childhood cancer is unknown and therefore had to be estimated based on assumptions.